title: BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine.
authors.affiliation: Hematology and Blood Transfusion Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil lazarini@unifesp.br sara@unicamp.br.|Department of Biological Sciences, Federal University of São Paulo, Diadema, Brazil.
authors.forename: Mariana
authors.initials: M
authors.lastname: Lazarini
authors.affiliation: Hematology and Blood Transfusion Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil.
authors.forename: João Agostinho
authors.initials: JA
authors.lastname: Machado-Neto
authors.affiliation: Hematology and Blood Transfusion Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil.
authors.forename: Adriana da Silva Santos
authors.initials: AD
authors.lastname: Duarte
authors.affiliation: Hematology and Blood Transfusion Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil.
authors.forename: Fernando Vieira
authors.initials: FV
authors.lastname: Pericole
authors.affiliation: Hematology and Blood Transfusion Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil.
authors.forename: Karla Priscila
authors.initials: KP
authors.lastname: Vieira
authors.affiliation: Hematology and Blood Transfusion Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil.
authors.forename: Fernanda S
authors.initials: FS
authors.lastname: Niemann
authors.affiliation: Hematology and Blood Transfusion Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil.
authors.forename: Marisa
authors.initials: M
authors.lastname: Alvarez
authors.affiliation: Hematology and Blood Transfusion Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil.|Department of Internal Medicine, University of São Paulo at Ribeirão Preto Medical School, Brazil.
authors.forename: Fabiola
authors.initials: F
authors.lastname: Traina
authors.affiliation: Hematology and Blood Transfusion Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil lazarini@unifesp.br sara@unicamp.br.
authors.forename: Sara Teresinha Olalla
authors.initials: ST
authors.lastname: Saad
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D001374:Azacitidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D001853:Bone Marrow / Q000737:chemistry; D016022:Case-Control Studies; D002460:Cell Line; D019175:DNA Methylation; D000077209:Decitabine; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000401:mortality / Q000473:pathology*; D008565:Membrane Proteins / Q000032:analysis*; D009190:Myelodysplastic Syndromes / Q000401:mortality / Q000473:pathology*; D011518:Proto-Oncogene Proteins / Q000032:analysis*; D016019:Survival Analysis; D016896:Treatment Outcome; D025521:Tumor Suppressor Proteins / Q000032:analysis*
chemical_list: D000964:Antimetabolites, Antineoplastic; C116838:BNIP3L protein, human; D008565:Membrane Proteins; D011518:Proto-Oncogene Proteins; D025521:Tumor Suppressor Proteins; D000077209:Decitabine; D001374:Azacitidine